ArticleJournal of movement disorders2026

Neuropsychiatric and Cognitive Safety of Subcutaneous Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease: Insights From a Real-World Cohort.

Clément Desjardins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.